Ireland has long established itself as a significant player in the global biopharmaceutical industry, boasting a thriving ecosystem supported by robust regulatory and governmental frameworks. With the recent appointment of Shane Ryan as the new president of the Irish Pharmaceutical Healthcare
Theratechnologies, a Quebec-based biopharmaceutical company, is currently navigating challenging waters as it faces potential disruptions in the supply of its crucial HIV medication, Egrifta SV. This drug is widely used to reduce excess abdominal fat in HIV patients suffering from lipodystrophy.
The biopharma sector has experienced a roller coaster of venture capital investments over the past decade and a half. From explosive growth driven by the COVID-19 pandemic to a more selective and strategic investment environment, the landscape continues to evolve rapidly. This article will delve
Kaida BioPharma, an emerging pharmaceutical company based in Fort Lauderdale, Florida, has announced the launch of its new corporate social media channels. This significant development aims to enhance the company’s presence across various platforms, including X, LinkedIn, and Facebook. By l
In a significant move likely to reshape the competitive landscape, the FDA has granted approval for Novartis’ Kisqali, when paired with an aromatase inhibitor, for the adjuvant treatment of HR-positive, HER2-negative stage 2 and 3 breast cancer at high risk of recurrence post-surgery. This approval
In a significant move for maternal and neonatal healthcare, Danish biotech company MinervaX has teamed up with German CDMO Wacker Biotech to develop a groundbreaking prophylactic vaccine for Group B Streptococcus (GBS) infections. This partnership marks a pivotal step in addressing a critical unmet
Walgreens, one of the nation’s largest retail pharmacy chains, is embarking on a monumental journey to transform its clinical trials business. This bold move, initiated in June 2022, leverages Walgreens' nationwide retail presence and extensive patient data to tap into the burgeoning p
The biopharmaceutical industry has long faced hurdles integrating advanced manufacturing technologies (AMTs) into commercial biomanufacturing. Despite the clear benefits of AMTs, including enhanced efficiency, scalability, and product quality, adoption rates remain sluggish. This article seeks to
In an exciting development, Scorpius Holdings has been selected as a member of the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV). This collaboration is expected to significantly enhance BARDA’s mission to accelerate the development of med
RedHill Biopharma Ltd., known for its focus on gastrointestinal and infectious diseases, has recently achieved compliance with Nasdaq's minimum bid price requirement. This milestone ensures that the specialty biopharmaceutical company will continue to be listed on the Nasdaq Capital Market, a
